Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall.
BACKGROUND
Basic fibroblast growth factor (bFGF) promotes vascular repair and angiogenesis and can induce in vitro tissue factor (TF), a potent agent initiating thrombogenesis, which probably plays a role in angiogenesis. We investigated whether bFGF administration induced TF expression by monocytes and vascular cells.


RESULTS
We studied TF expression in normally fed (n=16) and cholesterol-fed (2% for 6 weeks, n=16) rabbits. Animals were then randomized to receive intravenous bFGF (2.5 microg twice weekly for 3 weeks) or saline injections. TF expression was evaluated in mononuclear cells from arterial blood and in aortic sections by an immunohistochemical assay using a monoclonal anti-rabbit TF antibody (activator protein 1). Monocyte TF expression was increased by bFGF administration in both normal and hypercholesterolemic rabbits (129+/-45 versus 19+/-3 mU TF/1000 monocytes, P<0.05, and 31+/-12 versus 7+/-1 mU TF/1000 monocytes, P<0.005, respectively) and was further increased by stimulation of monocytes by endotoxin in vitro. TF expression was lower in hypercholesterolemic rabbits than in normal rabbits. In the media of the vascular wall, bFGF induced strong TF expression in normal rabbits and only weak TF expression in hypercholesterolemic ones.


CONCLUSIONS
This study demonstrates that systemic administration of bFGF induces an impressive increase of TF expression in circulating monocytes and in the vascular wall in normal and to a lower extent in hypercholesterolemic rabbits. The significance of this observation in terms of inducing thrombosis in vivo needs clarification.
Corseaux
D
D
Laboratoire d'Hématologie, Centre Hospitalier Régional Universitaire and Faculté de Médecine, Lille, France.
Meurice
T
T
Six
I
I
Rugeri
L
L
Ezekowitz
M D
MD
Rouvier
P
P
Bordet
R
R
Bauters
C
C
Jude
B
B
D000818:Animals; D001158:Arteries / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006937:Hypercholesterolemia / Q000378:metabolism; D007958:Leukocyte Count; D008297:Male; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010976:Platelet Count; D011516:Prothrombin / Q000032:analysis; D011817:Rabbits; D013925:Thromboplastin / Q000096:biosynthesis*
D016222:Fibroblast Growth Factor 2; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005170:Factor X; D005340:Fibrinogen; D013925:Thromboplastin